Company Profile
Fulgent Genetics, Inc. Stock Price, News & Analysis
- Ticker:
- FLGT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Fulgent Genetics is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
18.18 USD (+1.91%)
Close
Last updated: June 23, 2026 at 00:00
516.32M USD
Market cap
Why the stock is moving
FLGT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Fulgent Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Fulgent Genetics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Fulgent Genetics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Fulgent Genetics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Fulgent Presents Updated FID-007 Data at ASCO 2026
Source: Fulgent Genetics, Inc.
- 02
- 03
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
Source: Fulgent Genetics, Inc.
- 04
Fulgent Reports Third Quarter 2025 Financial Results
Source: Fulgent Genetics, Inc.
- 05
Fulgent to Participate in Upcoming Conferences
Source: Fulgent Genetics, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Fulgent Genetics, Inc. (FLGT)?
Fulgent Genetics, Inc. (FLGT) most recently closed at 18.18 USD, a +1.91% move versus the previous session.
What is the market cap of Fulgent Genetics, Inc. (FLGT)?
Fulgent Genetics, Inc. currently has a market capitalization of 516.32M USD on BioPharmSignal.
What does Fulgent Genetics, Inc. do?
Fulgent Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is FLGT stock listed?
Fulgent Genetics, Inc. (FLGT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Fulgent Genetics is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Fulgent?
Fulgent Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Fulgent Genetics, Inc. targeting with Fulgent?
Fulgent Genetics, Inc. is associated with genetic disease based on its company overview and current catalyst commentary.
What is Genetics?
Fulgent Genetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.